acute myeloid leukemia, AML, MM, Multiple Myeloma, Kahler’s disease, AMLprofiler, MMprofiler,

AMLprofiler.

The Most Efficient Diagnosis of Acute Myeloid Leukemia.

The AMLprofiler simplifies the challenging task to recognize Acute Myeloid Leukemia subtypes and make individualized therapy decisions. It delivers faster results and improved patient classification on an integrated and validated array platform.

 

In the USA the AMLprofiler is available for research use only.

Download now our new AMLprofiler brochure

 

 

  • graphicbestclassification2

    Seven assays in one

    The AMLprofiler replaces 7 separate assays based on 3 different technologies: cytogenetics, mutation analysis and expression analysis.

    Read more
     

  • AMLprofiler publications

    Valk, P.J.M. et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N. Engl. J. Med. 350, 1617-1628 (2004). Link

    Read more
     
  • graphic3days2diagnose

    AMLprofiler Assay: Three days to diagnosis

     

    Read more
     

  • AMLprofiler + Leukostrat FLT3

    Skyline Diagnostics and LabPMM GmbH have teamed up to offer comprehensive molecular diagnostic testing for AML:

    Read more
     
  • skyline 37

    Technical data

    Age at diagnosis 18 years or older, cytopathologically confirmed diagnosis of AML (including APL and MDS) or RAEB according to the WHO 2008 classification, primary, secondary or relapse, no prior allogeneic or autologous stem cell transplant, no Myeloproliferative Syndrome (MPS)

    Read more
     

Rotterdam Science Tower, Marconistraat 16, 3029 AK Rotterdam. The Netherlands, Europe. Phone: +31 (0)10 7038410. Fax: +31 (0)10 7043076. E-mail: info@skyline-diagnostics.com